EUVIMEDEUVIMED entdecken
Open Access

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

Jeffrey A Klomp iD, Jennifer E Klomp iD, Clint A Stalnecker iD, Kirsten L Bryant iD, A Cole Edwards, Kristina Drizyte-Miller iD, Priya S Hibshman, J Nathaniel Diehl iD, Ye S Lee iD, Alexis J Morales iD, Khalilah E Taylor iD, Sen Peng und 23 weitere

Science · 07.06.2024 · 384 (6700)

DOI: 10.1126/science.adk0775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 07.06.2024. Verfasst von Jeffrey A Klomp und 34 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Extracellular Signal-Regulated MAP Kinases, Gene Expression Regulation, Neoplastic, MAP Kinase Signaling System. Die Arbeit wurde bisher 151-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

How the KRAS oncogene drives cancer growth remains poorly understood. Therefore, we established a systemwide portrait of KRAS- and extracellular signal–regulated kinase (ERK)–dependent gene transcription in KRAS-mutant cancer to delineate the molecular mechanisms of growth and of inhibitor resistance. Unexpectedly, our KRAS-dependent gene signature diverges substantially from the frequently cited Hallmark KRAS signaling gene signature, is driven predominantly through the ERK mitogen-activated protein kinase (MAPK) cascade, and accurately reflects KRAS- and ERK-regulated gene transcription in KRAS-mutant cancer patients. Integration with our ERK-regulated phospho- and total proteome highlights ERK deregulation of the anaphase promoting complex/cyclosome (APC/C) and other components of the cell cycle machinery as key processes that drive pancreatic ductal adenocarcinoma (PDAC) growth. Our findings elucidate mechanistically the critical role of ERK in driving KRAS-mutant tumor growth and in resistance to KRAS-ERK MAPK targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, NeoplasticMAP Kinase Signaling SystemMutationPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)TranscriptomeAnimalsHumansMiceCell Line, TumorDrug Resistance, NeoplasmHEK293 Cells

Substanzen

Extracellular Signal-Regulated MAP KinasesKRAS protein, humanProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Cell Biology and Physiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Illumina, Inc., San Diego, CA 92121, USA.
  • Department of Cancer Biology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA.

ORCID-Profile: Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker, Kirsten L Bryant, Kristina Drizyte-Miller, J Nathaniel Diehl, Ye S Lee, Alexis J Morales, Khalilah E Taylor, Laura E Herring, Natalie K Barker, Jill Hallin, Saikat Chowdhury, Oluwadara Coker, Hey Min Lee, Craig M Goodwin, Prson Gautam, Peter Olson, James G Christensen, John P Shen, Scott Kopetz, Lee M Graves, Kian-Huat Lim, Andrea Wang-Gillam, Krister Wennerberg, Adrienne D Cox, Channing J Der

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Klomp, J. A., Klomp, J. E., Stalnecker, C. A., Bryant, K. L., Edwards, A. C., Drizyte-Miller, K., Hibshman, P. S., Diehl, J. N., Lee, Y. S., Morales, A. J., Taylor, K. E., Peng, S., Tran, N. L., Herring, L. E., Prevatte, A. W., Barker, N. K., Hover, L. D., Hallin, J., Sorokin, A., …, & Der, C. J. (2024). Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers. Science, 384(6700). https://doi.org/10.1126/science.adk0775

Vancouver

Klomp JA, Klomp JE, Stalnecker CA, Bryant KL, Edwards AC, Drizyte-Miller K, et al. Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers. Science. 2024;384(6700). doi:10.1126/science.adk0775

BibTeX
@article{Klomp2024,
  author = {Klomp, Jeffrey A and Klomp, Jennifer E and Stalnecker, Clint A and Bryant, Kirsten L and Edwards, A Cole and Drizyte-Miller, Kristina and Hibshman, Priya S and Diehl, J Nathaniel and Lee, Ye S and Morales, Alexis J and Taylor, Khalilah E and Peng, Sen and Tran, Nhan L and Herring, Laura E and Prevatte, Alex W and Barker, Natalie K and Hover, Laura D and Hallin, Jill and Sorokin, Alexey and Kanikarla, Preeti Marie and Chowdhury, Saikat and Coker, Oluwadara and Lee, Hey Min and Goodwin, Craig M and Gautam, Prson and Olson, Peter and Christensen, James G and Shen, John P and Kopetz, Scott and Graves, Lee M and Lim, Kian-Huat and Wang-Gillam, Andrea and Wennerberg, Krister and Cox, Adrienne D and Der, Channing J},
  title = {Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers},
  journal = {Science},
  year = {2024},
  volume = {384},
  number = {6700},
  doi = {10.1126/science.adk0775}
}
Kostenlos starten →